Map
Global Digital Health Exits (H1 2025)
A focused snapshot of H1 2025 digital health exits, contrasting the dominance of US activity with the global landscape, and highlighting the overwhelming role of M&A versus IPO.
Digital Health Exits — US vs Rest of World
US = 77 (72 M&A, 5 IPO) • ROW = 36 (35 M&A, 1 IPO) • Global = 119 (113 M&A, 6 IPO)
United States
77
M&A: 72 (93.5%)
IPO: 5 (6.5%)
Disclosed USD (subset)
$3.563B
— M&A
$2.976B CentralReach $1.7B; Accolade $621M; others
— IPO
$0.587B Hinge Health $437M; Omada $150M
Rest of World
36
M&A: 35 (97.2%)
IPO: 1 (2.8%)
Disclosed USD (subset)
$0.139B
— IPO
$139M MiRXES (Singapore)
— M&A
ND No disclosed amounts
Sources: Galen Growth (H1 2025 Exit Report), Rock Health (H1 2025 Market Overview),
Healthcare.Digital (Mid-Year 2025 Exits Analysis); Company announcements (Hinge Health $437M, Omada Health $150M, CentralReach $1.7B, Accolade $621M, SomaLogic $350M, 23andMe $305M, MiRXES $139M).
Digital Health Exits — US vs Rest of World
US = 77 (72 M&A, 5 IPO) • ROW = 36 (35 M&A, 1 IPO) • Global = 119 (113 M&A, 6 IPO)
United States
Disclosed: $3.56B
M&A 72
IPO 5
Rest of World
Disclosed: $0.139B
M&A 35
IPO 1
Sources: Galen Growth (H1 2025 Exit Report), Rock Health (H1 2025 Market Overview),
Healthcare.Digital (Mid-Year 2025 Exits Analysis); Company announcements (Hinge Health $437M, Omada Health $150M, CentralReach $1.7B, Accolade $621M, SomaLogic $350M, 23andMe $305M, MiRXES $139M).